NCT06624644 2026-04-22
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Linnaeus Therapeutics, Inc.
Phase 2/3 Recruiting
Linnaeus Therapeutics, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Eye & ENT Hospital of Fudan University